BioSpace News Archive

Magellan Health, Inc. (NASDAQ: MGLN) today announced that it will report its earnings for the second quarter ended on June 30, 2019 at approximately 6:30 a.m. Eastern on Tuesday, July 30, 2019.

Bruker Corporation (Nasdaq: BRKR) today announced it will report second quarter 2019 financial results on Thursday, August 1, 2019, after the market closes

111, Inc., a leading integrated online and offline healthcare platform, announced that its online retail pharmacy “1 Drugstore” has won two prestigious industry awards.

Financial results for the second quarter ending June 30, 2019, will be released after market close on Wednesday, August 7, 2019, followed the same day by a conference call and live webcast scheduled for 5:00 p.m. ET.

FUJIFILM Medical Systems U.S.A., Inc., a leading provider of diagnostic imaging and medical informatics solutions, recently expanded its breast imaging solutions with the launch of its Tomosynthesis Biopsy option for the ASPIRE Cristalle mammography system

Pfizer Inc. (NYSE:PFE) today announced the United States (U.S.) Food and Drug Administration (FDA) has approved RUXIENCE™ (rituximab-pvvr), a biosimilar to Rituxan® (rituximab),1 for the treatment of adult patients with non-Hodgkin’s lymphoma (NHL), chronic lymphocytic leukemia (CLL), and granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA).2

3B Scientific introduced to the global market 3B SMART ANATOMY, a new generation of anatomical models. 3B SMART ANATOMY is designed to close the gap between analog and digital learning.

GetInsured, a market leader in individual health insurance e-commerce, today announced it is the first company to pass the official Center for Medicare & Medicaid Services (CMS) audit and has been approved to offer Phase 3 Enhanced Direct Enrollment (EDE) technology.

Halozyme Therapeutics, Inc. (NASDAQ: HALO), a biotechnology company developing novel oncology and drug-delivery therapies, will webcast its Quarterly Update Conference Call for the second quarter 2019 on Tuesday, August 6 at 4:30 p.m. ET / 1:30 p.m. PT

Invacare Corporation (NYSE: IVC) (“Invacare” or the “company”) announces that it will release its financial results for the second quarter ended June 30, 2019, after the market closes on Monday, August 5, 2019